Loading clinical trials...
Loading clinical trials...
Immersive Versus Non-immersive Virtual Reality in Enhancing Upper Limb Functions Among Individuals With Subacute Stage Hemiplegia - A Randomized Controlled Trial
The goal of this randomized controlled trial is to compare the effectiveness of immersive virtual reality combined with conventional therapy to the effectiveness of non-immersive virtual reality combined with conventional therapy in enhancing upper limb function in subacute hemiplegic stroke patients.
The study is a single blinded randomized controlled trial in which the assessor will be blinded. Male and female participants aged between 28-55 years are included in the study. Participants are selected based on inclusion and exclusion criteria and are later randomly assigned to Group 1 and Group 2. Group 1 - Conventional therapy and Immersive Virtual Reality Group 2 - Conventional therapy and Non-Immersive Virtual Reality Primary Outcome measures include the Fugl Meyer Assessment for Upper limb and Graded Wolf Motor Function test for upper limb. Secondary Outcome measure is the Stroke Specific Quality of Life Scale (SS-QOL) Questionnaire. Therapy session starts with 15 minutes of stretching and strengthening exercises of the affected arm followed by 45 minutes of Immersive / Non Immersive virtual reality training. Follow up assessment is done 6 weeks post intervention. The baseline assessment score and follow up assessment scores will be compared.
Age
28 - 55 years
Sex
ALL
Healthy Volunteers
No
Thumbay Physical Therapy and Rehabilitation Hospital
Ajman, United Arab Emirates
Start Date
March 5, 2024
Primary Completion Date
January 5, 2025
Completion Date
January 5, 2025
Last Updated
September 26, 2024
30
ESTIMATED participants
Oculus Quest 3
DEVICE
Neofect Smartboard and Tyromotion Myro
DEVICE
Lead Sponsor
Gulf Medical University
NCT07299162
NCT06541015
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions